Skip to content

The role of EMDR in the reduction of psychological symptoms in patients with personality disorders.

The role of EMDR in the reduction of psychological symptoms in patients with personality disorders. - EMDR in personality disorders.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON47439
Enrollment
96
Registered
2017-08-31
Start date
2017-10-24
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Personality disorder

Interventions

Patients in the experimental condition will receive five weekly 90 minute sessions of EMDR. The EMDR-treatment will be given following the standard protocol, added in the appendix (F4). In the wait

Sponsors

GGZ Delfland (Delft)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Aged between 18 and 65 years 2) Primary diagnosis is a personality disorder diagnosed with the SCID-II during intake. 3) Ability to understand and speak the Dutch language.

Exclusion criteria

Exclusion criteria: 1) A posttraumatic stress disorder (determined with the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)) 2) High suicide risk (operationalized by a suicide attempt within the past 6 months, current suicidal intention or severe automutilation). 3) Participation in another study. 4) Inability to understand and talk Dutch

Design outcomes

Primary

MeasureTime frame
The main study parameter is the difference in the level of psychological symptoms between the patients in the experimental and WL condition, measured with the Brief Symptom Inventory (BSI).

Secondary

MeasureTime frame
The secundary study parameter is the difference in the level of psychological symptoms between the patients in the experimental and WL condition, measured with the Brief Symptom Inventory (BSI), three months after the treatment as usual for personality disorders is started. Also weekly treatment results are monitored with the OQ-45. Another secundary objective is the difference in the global level of personality functioning between the patients in the experimental and WL condition, measured with the GAPD.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)